Search Results 1-10 of 13208 for Tyrosine

  1. Nitisinone (oral route) - Side effects & dosage - Mayo Clinic

    Description. Nitisinone is used to treat hereditary tyrosinemia type 1, which is too much tyrosine in the blood. It helps to prevent high levels of tyrosine ...

  2. [18F] Fluoroethyl-L-tyrosine PET/MRI for identifying small functional pituitary adenomas - Mayo Clinic

    About this study. The purpose of this research is to evaluate the diagnostic role and clinical efficacy of [18F]FET-PET/MRI in detecting MRI-occult primary ...

  3. Pharmacogenomic Testing In Patients With Hand-Foot Skin Reaction On Tyrosine Kinase Inhibitors - Mayo Clinic

    Clinical Trials · Pharmacogenomic Testing In Patients With Hand-Foot Skin Reaction On Tyrosine Kinase Inhibitors · More about research at Mayo Clinic · Mayo Clinic ...

  4. Testing The Use Of Steroids And Tyrosine Kinase Inhibitors With Blinatumomab Or Chemotherapy For Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia In Adults - Mayo Clinic

    About this study. This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same ...

  5. MAOIs and diet: Is it necessary to restrict tyramine? - Mayo Clinic

    It's found naturally in the body. It's also found in certain foods. Medicines used to treat depression called monoamine oxidase inhibitors (MAOIs) can affect ...

  6. A Study Of Tyrosine Kinase Inhibitor ICP-022 In Patients With R/r B-Cell Malignancies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study Of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) In Participants With Chronic Lymphocytic Leukemia (CLL) And Other B-cell Malignancies - Mayo Clinic

    A Study Of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) In Participants With Chronic Lymphocytic Leukemia (CLL) And Other B-cell ...

  8. A Trial Of The FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered As Maintenance Therapy Following Allogeneic Transplant For Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML) - Mayo Clinic

    A Trial Of The FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered As Maintenance Therapy Following Allogeneic Transplant For Patients With ...

  9. A Study Of An Integrated Approach To Treating Recurrent Lung Adenocarcinomas Resistant To Tyrosine Kinase Inhibitors - Mayo Clinic

    Clinical Trials · A Study Of An Integrated Approach To Treating Recurrent Lung Adenocarcinomas Resistant To Tyrosine Kinase Inhibitors · More about research at ...

  10. Chemical Biology of Microbes and Membrane Proteins: Nate Traaseth - Mayo Clinic Research

    Cellular signaling mediated by receptor tyrosine kinases. Receptor tyrosine kinase genes in humans regulate essential biological processes, including ...